HHS may reconsider blocked 340B rebate pilot after courts halt the program, signaling potential changes for drug discount policies in 2024.

The First Circuit upheld a district court’s pause of the controversial pilot on Wednesday. It’s a setback for the Trump ...

On January 7, 2026, the First Circuit Court of Appeals denied the federal government’s emergency motion to stay a district ...

The Health Resources and Services Administration (HRSA) has updated its guidelines to include self collection testing for ...

This past September, a sub-agency of the Department of Health and Human Services (HHS) threatened to kick a pharmaceutical company out of Medicare because the company, in line with federal law, ...

Over the past several months, the Health Resources and Services Administration (HRSA) has issued a number of guidance updates related to the agency's expectations for health care providers ...

For the first time, many people in the United States who should be screened for cervical cancer will have an alternative to ...

The Health Resources and Services Administration yesterday announced updated cervical cancer screening guidelines, including ...

Drugmaker Johnson and Johnson is suing the Department of Health and Human Services and the Health Resources and Services Administration for blocking its new 340B rebate model, and is seeking to verify ...

The Biden administration is threatening Johnson & Johnson with fines if the drugmaker follows through with planned changes to how it offers hospitals savings on two widely prescribed drugs in the 340B ...